[Skip to Content]

Upstate Active Clinical Trials

Study Title:

AREN1921 - Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)

What is the purpose of the study? (in Layman's terms, please describe the study)

Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)

Upstate Institutional Review Board (IRB) Number:

1716037

Study/Protocol ID:

AREN1921

Study Phase:

II

Patient Age Group:

Children

Principal Investigator:

Melanie A Comito

Who is eligible?

Patients must be ≤ 30 years old at study enrollment.

What is involved if I participate?

  • How long is the study?
    until accrual is met
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    surgery, blood draws, radiation therapy, imaging

Where will the study take place?

SUNY Upstate Medical University

Other Information:

N/A

Who can I contact for more information?

Name: Karen B Bilynsky
Phone: 315-464-7601
Email: [email protected]

Return to Previous Page || Search Again

Top